Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone

NCT07308184 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes (DM)
Diabetes Mellitus Type 2

Interventions

DRUG: IN-B00009
DRUG: Placebo

Sponsor

HK inno.N Corporation